As a new class of sentinel lymph node (SLN) tracers for photoacoustic (PA) imaging, Au nanocages offer the advantages of noninvasiveness, strong optical absorption in the near-infrared region (for deep penetration), and accumulation in higher concentrations than the initial injected solution. By monitoring the amplitude changes of PA signals in an animal model, we quantified the accumulations of nanocages in SLNs over time. Based on this method, we quantitatively evaluated the kinetics of gold nanocages in SLN in terms of concentration, size, and surface modification. We could detect the SLN at an Au nanocage injection concentration of 50 pM and a dose of 100 μL in vivo. This concentration is about 40 times less than the previously reported value. We also investigated the influence of nanocages' size (50 nm and 30 nm in edge length), and the effects of surface modification (with positive, or neutral, or negative surface charges). The results are helpful to develop this AuNC-based PA imaging system for noninvasive lymph node mapping, providing valuable information about metastatic cancer staging.
INTRODUCTION
The metastatic spread of cancer cells occurs by invading the adjacent tissue and disseminating in the blood stream via the lymphatic system. 1 The closest lymph node that receives the drainage from a cancer-containing area is called the sentinel lymph node (SLN). The SLN represents the most possible first location of metastatic spread. To reduce the side effects of axillary lymph node dissection, 2 sentinel lymph node biopsy (SLNB) is widely performed and has become the standard for axillary staging in breast cancer patients. 3 However, SLNB requires ionizing imaging and is invasive.
Recently, ultrasound-guided fine needle aspiration biopsy (FNAB) has been clinically evaluated as a minimally invasive procedure. 4 This technique requires accurate identification of the SLN, which initiates studies to develop accurate, nonionizing, and noninvasive methods for SLN mapping. Photoacoustic (PA) imaging modality is a nonionizing, noninvasive, and high-resolution imaging technique that provides strong optical absorption contrast. 5, 6 Since the spatial resolution of this technique typically depends on ultrasound parameters, the imaging depth can be extended to the optical quasidiffusive or diffusive regime while keeping high resolution. It can achieve up to ~50 mm imaging depth in biological tissues.
Gold nanocages (AuNCs), which are hollow porous nanoparticles, have proper size range (30-100 nm) to stay within the SLN with secure fast migration and sufficient duration of trapping for imaging. 8 AuNCs also can be utilized effectively for delivering and targeting because of their easily modifiable surfaces. 9, 10 Other advantages of AuNCs include biocompatibility, a lack of heavy metal toxicity, a tunable localized surface plasmon resonance (LSPR) peak, encapsulated site-specific drug delivery, 11 and strong optical absorption in the near inferred spectral region. Moreover, gold has been approved and used for various phase-I clinical trials (e.g., http://www.cytimmune.com and http://www.nanospectra.com). These features suggest AuNC a promising candidate as contrast agent in the PA SLN mapping. Our previous work has successfully demonstrated a proof-of-concept use of AuNCs for SLN imaging by PA tomography. 12 However, many parameters still need to be examined and optimized before this system can be further considered for potential clinical use. In the present paper, we quantitatively evaluated in vivo kinetics of AuNCs in lymphatic systems by PA imaging on a rat model. The influences of the injection concentration, the size, and the surface charge were systematically examined. These evaluations are helpful to optimize the experimental parameters of AuNCs for lymph node metastases by in vivo noninvasive PA mapping.
MATERIALS AND METHODS

Synthesis and Surface Modification of AuNCs
The method The Au nanocages were synthesized using the galvanic replacement reaction between Ag nanocubes and chloroauric acid in water according to our published protocol. 13 To obtain different surface charges, the nanocages were derivatized with SH-PEG 5000 -X (X=OMe, NH 2 , and COOH; all from Laysan Bio; Mw ≈ 5,000). In a typical process, 0.1 mL of HS-PEG 5000 -X aqueous solution (0.1 mM) and 0.1 mL of AuNCs aqueous suspension (1 nM in terms of particles) were added to 2.8 mL deionized water. The mixture was kept stirring at 4 o C overnight. After that, the mixture was centrifuged at 14,000 rpm for 15 min and the supernatant was decanted to remove the excess PEG. The PEGylatedAuNCs were then washed with water twice and re-suspended in water at a concentration of 200 pM (in terms of particles) for in vivo studies.
Photoacoustic Tomography System
A reflection-mode PA imaging system (Scheme 1 in ref. 14) was used for all PA experiments.
14 Light source: tunable Ti:sapphire laser (760nm, LT-2211A, LOTIS TII) pumped by a Q-switched Nd:YAG (LS-2137/2, LOTIS TII); pulse width <15 ns, pulse repetition rate 10 Hz. The incident laser fluence on the sample surface was controlled to conform to the American National Standards Institute standards. Transducer: 5 MHz central frequency, spherically focused, 2.54 cm focul length; 1.91 cm diameter active area element, 72% bandwidth (V308, Panametrics-NDT); low-noise amplifier (5072PR, Panametrics-NDT). Data were acquired with a digital oscilloscope (TDS 5054, Tektronix).
Animal Handling
All animal experiments were in compliance with the Washington University Institutional Animal Care and Use Committee. Sprague-Dawley rats weighting 200-300 g (Harlan, Indianapolis, IN) were anesthetized with ketamine and xylazine cocktail (87 mg/kg and 13 mg/kg, respectively, i.p.) at a dose of 0.15 mL per 100 g body weight. The hair in the left axillary region was removed by gentle clipping and depilatory cream before imaging. PA imaging was achieved before and after a 0.1 mL intradermal injection of AuNC solution in the left forepaw pad. Full anesthesia of the animal was maintained throughout the experiment by using vaporized isoflurane (1 L/min of oxygen and 0.75% isoflurane), and vitals were monitored by a pulse oximeter (NOMIN Medical INC., 2000SA). The body temperatures of the rats were maintained by a water heating pad. After the imaging acquisition, the rats were euthanized by overdosed pentobarbital. (Fig. 2A) 
